| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.058 | 0.06 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.07 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |